{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T23:17:14Z","timestamp":1795043834082,"version":"4.10.2"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:00:00Z","timestamp":1736467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:00:00Z","timestamp":1736467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2023M743016"],"award-info":[{"award-number":["2023M743016"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2022M722766"],"award-info":[{"award-number":["2022M722766"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82403929"],"award-info":[{"award-number":["82403929"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LQ24H160007"],"award-info":[{"award-number":["LQ24H160007"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Postdoctoral Fellowship Program of CPSF","award":["GZB20230642"],"award-info":[{"award-number":["GZB20230642"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematol Oncol"],"DOI":"10.1186\/s13045-025-01660-y","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T02:34:12Z","timestamp":1736476452000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":201,"title":["Global status and attributable risk factors of breast, cervical, ovarian, and uterine cancers from 1990 to 2021"],"prefix":"10.1186","volume":"18","author":[{"given":"Tianye","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoxiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyi","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qionghua","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingwei","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyun","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kongming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,10]]},"reference":[{"key":"1660_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"1660_CR2","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13045-024-01593-y","volume":"17","author":"T Zhou","year":"2024","unstructured":"Zhou T, Wang X, Zhang J, Zhou E, Xu C, Shen Y, et al. Global burden of thyroid cancer from 1990 to 2021: a systematic analysis from the global burden of Disease Study 2021. J Hematol Oncol. 2024;17:74.","journal-title":"J Hematol Oncol"},{"key":"1660_CR3","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13045-024-01623-9","volume":"17","author":"W Li","year":"2024","unstructured":"Li W, Liang H, Wang W, Liu J, Liu X, Lao S, et al. Global cancer statistics for adolescents and young adults: population based study. J Hematol Oncol. 2024;17:99.","journal-title":"J Hematol Oncol"},{"key":"1660_CR4","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s40364-021-00310-y","volume":"9","author":"M Yi","year":"2021","unstructured":"Yi M, Li T, Niu M, Luo S, Chu Q, Wu K. Epidemiological trends of women\u2019s cancers from 1990 to 2019 at the global, regional, and national levels: a population-based study. Biomark Res. 2021;9:55.","journal-title":"Biomark Res"},{"key":"1660_CR5","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1016\/S0140-6736(24)00769-4","volume":"403","author":"CJL Murray","year":"2024","unstructured":"Murray CJL. Findings from the global burden of Disease Study 2021. Lancet. 2024;403:2259\u201362.","journal-title":"Lancet"},{"key":"1660_CR6","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s40364-024-00649-y","volume":"12","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Huang G, Cai X, Liu Y, Qian B, Li D. Global, regional, and national burden of acute myeloid leukemia, 1990\u20132021: a systematic analysis for the global burden of disease study 2021. Biomark Res. 2024;12:101.","journal-title":"Biomark Res"},{"key":"1660_CR7","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s13045-024-01640-8","volume":"17","author":"Z Wu","year":"2024","unstructured":"Wu Z, Xia F, Lin R. Global burden of cancer and associated risk factors in 204 countries and territories, 1980\u20132021: a systematic analysis for the GBD 2021. J Hematol Oncol. 2024;17:119.","journal-title":"J Hematol Oncol"},{"key":"1660_CR8","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1016\/S0140-6736(24)00367-2","volume":"403","author":"GBD 2021 Causes of Death Collaborators","year":"2024","unstructured":"GBD 2021 Causes of Death Collaborators. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the global burden of Disease Study 2021. Lancet. 2024;403:2100\u201332.","journal-title":"Lancet"},{"key":"1660_CR9","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","author":"GBD 2021 Diseases and Injuries Collaborators","year":"2024","unstructured":"GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the global burden of Disease Study 2021. Lancet. 2024;403:2133\u201361.","journal-title":"Lancet"},{"key":"1660_CR10","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1016\/S0140-6736(24)00933-4","volume":"403","author":"GBD 2021 Risk Factors Collaborators","year":"2024","unstructured":"GBD 2021 Risk Factors Collaborators. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990\u20132021: a systematic analysis for the global burden of Disease Study 2021. Lancet. 2024;403:2162\u2013203.","journal-title":"Lancet"},{"key":"1660_CR11","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13045-020-00908-z","volume":"13","author":"M Yi","year":"2020","unstructured":"Yi M, Li A, Zhou L, Chu Q, Song Y, Wu K. The global burden and attributable risk factor analysis of acute myeloid leukemia in 195 countries and territories from 1990 to 2017: estimates based on the global burden of disease study 2017. J Hematol Oncol. 2020;13:72.","journal-title":"J Hematol Oncol"},{"key":"1660_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40164-020-00181-3","volume":"9","author":"X Bai","year":"2020","unstructured":"Bai X, Yi M, Dong B, Zheng X, Wu K. The global, regional, and national burden of kidney cancer and attributable risk factor analysis from 1990 to 2017. Exp Hematol Oncol. 2020;9:27.","journal-title":"Exp Hematol Oncol"},{"key":"1660_CR13","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13045-023-01497-3","volume":"16","author":"S Zhu","year":"2023","unstructured":"Zhu S, Wu Y, Song B, Yi M, Yan Y, Mei Q, et al. Recent advances in targeted strategies for triple-negative breast cancer. J Hematol Oncol. 2023;16:100.","journal-title":"J Hematol Oncol"},{"key":"1660_CR14","doi-asserted-by":"publisher","first-page":"e005543","DOI":"10.1136\/jitc-2022-005543","volume":"10","author":"M Yi","year":"2022","unstructured":"Yi M, Wu Y, Niu M, Zhu S, Zhang J, Yan Y, et al. Anti-TGF-\u03b2\/PD-L1 bispecific antibody promotes T cell infiltration and exhibits enhanced antitumor activity in triple-negative breast cancer. J Immunother Cancer. 2022;10:e005543.","journal-title":"J Immunother Cancer"},{"key":"1660_CR15","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12943-023-01805-y","volume":"22","author":"F Ye","year":"2023","unstructured":"Ye F, Dewanjee S, Li Y, Jha NK, Chen ZS, Kumar A, et al. Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer. Mol Cancer. 2023;22:105.","journal-title":"Mol Cancer"},{"key":"1660_CR16","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s10549-015-3628-4","volume":"154","author":"A Macacu","year":"2015","unstructured":"Macacu A, Autier P, Boniol M, Boyle P. Active and passive smoking and risk of breast cancer: a meta-analysis. Breast Cancer Res Treat. 2015;154:213\u201324.","journal-title":"Breast Cancer Res Treat"},{"key":"1660_CR17","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1200\/JCO.19.00435","volume":"38","author":"RT Chlebowski","year":"2020","unstructured":"Chlebowski RT, Aragaki AK, Anderson GL, Pan K, Neuhouser ML, Manson JE, et al. Dietary modification and breast Cancer mortality: long-term Follow-Up of the women\u2019s Health Initiative Randomized Trial. J Clin Oncol. 2020;38:1419\u201328.","journal-title":"J Clin Oncol"},{"key":"1660_CR18","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1093\/humrep\/deaa102","volume":"35","author":"Z Blumenfeld","year":"2020","unstructured":"Blumenfeld Z, Gleicher N, Adashi EY. Transiently increased risk of breast cancer after childbirth: implications for fertility treatments and surrogacy. Hum Reprod. 2020;35:1253\u20135.","journal-title":"Hum Reprod"},{"key":"1660_CR19","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1136\/ijgc-2022-003703","volume":"33","author":"D Viveros-Carre\u00f1o","year":"2023","unstructured":"Viveros-Carre\u00f1o D, Fernandes A, Pareja R. Updates on cervical cancer prevention. Int J Gynecol Cancer. 2023;33:394\u2013402.","journal-title":"Int J Gynecol Cancer"},{"key":"1660_CR20","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.6004\/jnccn.2023.0062","volume":"21","author":"NR Abu-Rustum","year":"2023","unstructured":"Abu-Rustum NR, Yashar CM, Arend R, Barber E, Bradley K, Brooks R, et al. NCCN Guidelines\u00ae insights: Cervical Cancer, Version 1.2024. J Natl Compr Canc Netw. 2023;21:1224\u201333.","journal-title":"J Natl Compr Canc Netw"},{"key":"1660_CR21","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3322\/caac.21696","volume":"71","author":"PE Castle","year":"2021","unstructured":"Castle PE, Einstein MH, Sahasrabuddhe VV. Cervical cancer prevention and control in women living with human immunodeficiency virus. CA Cancer J Clin. 2021;71:505\u201326.","journal-title":"CA Cancer J Clin"},{"key":"1660_CR22","doi-asserted-by":"publisher","first-page":"e200421","DOI":"10.1001\/jamaoncol.2020.0421","volume":"6","author":"A Babic","year":"2020","unstructured":"Babic A, Sasamoto N, Rosner BA, Tworoger SS, Jordan SJ, Risch HA, et al. Association between Breastfeeding and Ovarian Cancer Risk. JAMA Oncol. 2020;6:e200421.","journal-title":"JAMA Oncol"},{"key":"1660_CR23","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1093\/humupd\/dmq030","volume":"17","author":"D Cibula","year":"2011","unstructured":"Cibula D, Widschwendter M, M\u00e1jek O, Dusek L. Tubal ligation and the risk of ovarian cancer: review and meta-analysis. Hum Reprod Update. 2011;17:55\u201367.","journal-title":"Hum Reprod Update"},{"key":"1660_CR24","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12943-024-01967-3","volume":"23","author":"L Wang","year":"2024","unstructured":"Wang L, Wang X, Zhu X, Zhong L, Jiang Q, Wang Y, et al. Drug resistance in ovarian cancer: from mechanism to clinical trial. Mol Cancer. 2024;23:66.","journal-title":"Mol Cancer"},{"key":"1660_CR25","doi-asserted-by":"publisher","first-page":"e87","DOI":"10.3802\/jgo.2024.35.e87","volume":"35","author":"Y Kobayashi","year":"2024","unstructured":"Kobayashi Y, Shimada M, Tamate M, Cho HW, Zhu J, Chou HH, et al. Current treatment strategies for ovarian cancer in the East Asian Gynecologic Oncology Trial Group (EAGOT). J Gynecol Oncol. 2024;35:e87.","journal-title":"J Gynecol Oncol"},{"key":"1660_CR26","doi-asserted-by":"publisher","first-page":"m3773","DOI":"10.1136\/bmj.m3773","volume":"371","author":"L Kuroki","year":"2020","unstructured":"Kuroki L, Guntupalli SR. Treatment of epithelial ovarian cancer. BMJ. 2020;371:m3773.","journal-title":"BMJ"},{"key":"1660_CR27","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.ajog.2022.05.016","volume":"227","author":"CM Eakin","year":"2022","unstructured":"Eakin CM, Liao CI, Salani R, Cohen JG, Kapp DS, Chan JK. The association of obesity with type I uterine cancer-is this an oversimplification? Am J Obstet Gynecol. 2022;227:538\u20139.","journal-title":"Am J Obstet Gynecol"},{"key":"1660_CR28","doi-asserted-by":"publisher","first-page":"4646","DOI":"10.1111\/cas.14667","volume":"111","author":"T Masuda","year":"2020","unstructured":"Masuda T, Ogawa K, Kamatani Y, Murakami Y, Kimura T, Okada Y. A mendelian randomization study identified obesity as a causal risk factor of uterine endometrial cancer in Japanese. Cancer Sci. 2020;111:4646\u201351.","journal-title":"Cancer Sci"},{"key":"1660_CR29","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1093\/annonc\/mdw310","volume":"27","author":"K Papatla","year":"2016","unstructured":"Papatla K, Huang M, Slomovitz B. The obese endometrial cancer patient: how do we effectively improve morbidity and mortality in this patient population? Ann Oncol. 2016;27:1988\u201394.","journal-title":"Ann Oncol"},{"key":"1660_CR30","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s10654-015-0017-6","volume":"30","author":"D Schmid","year":"2015","unstructured":"Schmid D, Behrens G, Keimling M, Jochem C, Ricci C, Leitzmann M. A systematic review and meta-analysis of physical activity and endometrial cancer risk. Eur J Epidemiol. 2015;30:397\u2013412.","journal-title":"Eur J Epidemiol"},{"key":"1660_CR31","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1186\/s12885-021-08580-3","volume":"21","author":"JY Kim","year":"2021","unstructured":"Kim JY, Lee DW, Kim MJ, Shin JE, Shin YJ, Lee HN. Secondhand smoke exposure, diabetes, and high BMI are risk factors for uterine cervical cancer: a cross-sectional study from the Korea national health and nutrition examination survey (2010\u20132018). BMC Cancer. 2021;21:880.","journal-title":"BMC Cancer"},{"key":"1660_CR32","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1001\/jamaoncol.2022.7826","volume":"9","author":"S Chen","year":"2023","unstructured":"Chen S, Cao Z, Prettner K, Kuhn M, Yang J, Jiao L, et al. Estimates and projections of the Global Economic cost of 29 cancers in 204 countries and territories from 2020 to 2050. JAMA Oncol. 2023;9:465\u201372.","journal-title":"JAMA Oncol"}],"container-title":["Journal of Hematology &amp; Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-025-01660-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13045-025-01660-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-025-01660-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T03:06:27Z","timestamp":1736478387000},"score":1,"resource":{"primary":{"URL":"https:\/\/jhoonline.biomedcentral.com\/articles\/10.1186\/s13045-025-01660-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,10]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1660"],"URL":"https:\/\/doi.org\/10.1186\/s13045-025-01660-y","relation":{},"ISSN":["1756-8722"],"issn-type":[{"value":"1756-8722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,10]]},"assertion":[{"value":"7 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5"}}